Hassanein Mohamed, Arrigain Susana, Schold Jesse D, Nakhoul Georges N, Navaneethan Sankar D, Mehdi Ali, Sekar Arjun, Tabbara Jad, Taliercio Jonathan J
University of Mississippi Medical Center, Jackson, Mississippi.
Department of Quantitative Health Science, Cleveland Clinic, Cleveland, Ohio.
Kidney Med. 2022 Oct 6;4(12):100554. doi: 10.1016/j.xkme.2022.100554. eCollection 2022 Dec.
RATIONALE & OBJECTIVE: Dysnatremias have been associated with an increased risk of mortality in the chronic kidney disease (CKD) population. Our objective is to identify the prevalence of and risk factors associated with dysnatremias in a CKD population and assess the association of dysnatremias with kidney failure and mortality among patients with CKD enrolled in the Chronic Renal Insufficiency Cohort Study.
Analysis of prospective cohort study.
SETTING & PARTICIPANTS: Adult patients aged 21-74 years with CKD from the Chronic Renal Insufficiency Cohort study.
Baseline and time-dependent hyponatremia and hypernatremia.
All-cause mortality and kidney failure.
Baseline characteristics were compared using χ tests for categorical variables, analysis of variance for age, and Kruskal-Wallis tests for laboratory variables. Cox proportional hazards models and competing risk models were used to evaluate the association between baseline sodium level and overall mortality.
Of a total of 5,444 patients with CKD, 486 (9%) had hyponatremia and 53 (1%) had hypernatremia. Altogether, 1,508 patients died and 1,206 reached kidney failure. In adjusted Cox models, time-dependent dysnatremias were strongly associated with mortality for both hyponatremia (HR, 1.38; 95% CI, 1.16-1.64) and hypernatremia (HR, 1.54; 95% CI, 1.04-2.29). Factors associated with hyponatremia included female sex, diabetes, and hypertension. Regardless of age, time-dependent hypernatremia was associated with an increased risk of kidney failure (HR, 1.64; 95% CI, 1.06-2.53). Baseline and time-dependent hyponatremia were associated with an increased risk of kidney failure in patients younger than 65 (baseline hyponatremia HR, 1.30; 95% CI, 1.03-1.64 and time-dependent hyponatremia HR, 1.36; 95% CI, 1.09-1.70) but not among patients aged >65 years.
Inability to establish causality and lack of generalizability to hospitalized patients.
Dysnatremias are prevalent among ambulatory CKD patients and are associated with mortality and kidney failure. Time-dependent dysnatremias were significantly associated with mortality in patients with CKD. Time-dependent hypernatremia was associated with progression to kidney failure. Baseline and time-dependent hyponatremia were associated with an increased risk of progression to kidney failure in those younger than 65 years.
在慢性肾脏病(CKD)人群中,钠代谢紊乱与死亡风险增加相关。我们的目的是确定CKD人群中钠代谢紊乱的患病率及相关危险因素,并评估在慢性肾功能不全队列研究中纳入的CKD患者中,钠代谢紊乱与肾衰竭及死亡之间的关联。
前瞻性队列研究分析。
慢性肾功能不全队列研究中年龄在21 - 74岁的成年CKD患者。
基线及随时间变化的低钠血症和高钠血症。
全因死亡率和肾衰竭。
使用卡方检验比较分类变量的基线特征,使用方差分析比较年龄,使用Kruskal - Wallis检验比较实验室变量。采用Cox比例风险模型和竞争风险模型评估基线钠水平与总死亡率之间的关联。
在总共5444例CKD患者中,486例(9%)有低钠血症,53例(1%)有高钠血症。共有1508例患者死亡,1206例达到肾衰竭。在调整后的Cox模型中,随时间变化的钠代谢紊乱与低钠血症(风险比[HR],1.38;95%置信区间[CI],1.16 - 1.64)和高钠血症(HR,1.54;95% CI,1.04 - 2.29)的死亡率均密切相关。与低钠血症相关的因素包括女性、糖尿病和高血压。无论年龄如何,随时间变化的高钠血症与肾衰竭风险增加相关(HR,1.64;95% CI,1.06 - 2.53)。基线及随时间变化的低钠血症与65岁以下患者的肾衰竭风险增加相关(基线低钠血症HR,1.30;95% CI,1.03 - 1.64;随时间变化的低钠血症HR,1.36;95% CI,1.09 - 1.70),但在65岁以上患者中无此关联。
无法确立因果关系,且对住院患者缺乏普遍性。
钠代谢紊乱在非卧床CKD患者中普遍存在,且与死亡率和肾衰竭相关。随时间变化的钠代谢紊乱与CKD患者的死亡率显著相关。随时间变化的高钠血症与肾衰竭进展相关。基线及随时间变化的低钠血症与65岁以下患者进展至肾衰竭的风险增加相关。